May’s top stories: Thermo Fisher Scientific buys Patheon for $7.2bn, AstraZeneca to sell rights for Seloken
Thermo Fisher Scientific agreed to buy Patheon for $7.2bnUS based company Thermo Fisher Scientific agreed to acquire Dutch contract development…